Company Filing History:
1 out of 181 
1 out of 480 
Years Active: 1999-2001
Title: Innovator Pedro A. Bonilla: Advancements in Microbial Control and Immunoassays
Introduction: Pedro A. Bonilla, an accomplished inventor based in Memphis, TN, has made significant contributions to the fields of microbial control and immunoassay technologies. With a total of two patents to his name, Bonilla's innovative work demonstrates his commitment to advancing science through practical and effective solutions.
Latest Patents: Bonilla's latest patents showcase his expertise in developing formulations that benefit various industries. His first patent revolves around solid TCMTB formulations, which provide an efficient means of controlling the growth of microorganisms. This solid formulation minimizes user contact and simplifies packaging, containing TCMTB adsorbed onto a water-soluble, salt carrier matrix. The innovative application of this technology highlights its potential in a range of biocide applications.
The second patent focuses on novel phencyclidine analogs for immunoassays. These analogs are designed to interact with anti-PCP antibodies and are essential for enhancing the accuracy of immunoassay testing. This development offers promising avenues for research and diagnostics in medical and scientific fields.
Career Highlights: Throughout his career, Pedro A. Bonilla has worked with esteemed organizations such as Buckman Laboratories International, Inc. and Roche Diagnostics GmbH. His experience in these companies has allowed him to refine his skills and contribute effectively to groundbreaking projects.
Collaborations: Bonilla has collaborated with notable colleagues, including James C. Lee and Richard A. Clark. These partnerships have likely enhanced his innovation process, allowing for interdisciplinary approaches to complex challenges.
Conclusion: Pedro A. Bonilla is a notable inventor whose work in solid TCMTB formulations and phencyclidine analogs showcases his inventive spirit and dedication to science. His contributions continue to pave the way for advancements in microbial control and immunoassays, making him a valued figure in his fields of expertise.